Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May-Jun:97:107176.
doi: 10.1016/j.ntt.2023.107176. Epub 2023 Apr 11.

A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use

Lydia Bierce  1 , Alexandra R Tabachnick  2 , Rina D Eiden  3 , Mary Dozier  4 , Madelyn H Labella  5
Affiliations

A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use

Lydia Bierce et al. Neurotoxicol Teratol. 2023 May-Jun.

Abstract

Background: Prenatal opioid exposure has been associated with developmental deficits during infancy, but the literature is limited by simple group comparisons and lack of appropriate controls. Previously published research with the current sample documented unique associations between prenatal opioid exposure and developmental outcomes at three and six months, but less is known about associations later in infancy.

Method: The current study examined pre- and postnatal opioid and polysubstance exposure as predictors of parent-reported developmental status at 12 months of age. Participants were 85 mother-child dyads, oversampled for mothers taking opioid treatment medications during pregnancy. Maternal opioid and polysubstance use were reported using the Timeline Follow-Back Interview during the third trimester of pregnancy or up to one month postpartum and updated through the child's first year of life. Seventy-eight dyads participated in a 12-month assessment, including 68 with parent-reported developmental status on Ages and Stages Questionnaire.

Results: At 12 months, average developmental scores fell within normal ranges and prenatal opioid exposure was not significantly related to any developmental outcomes. However, more prenatal alcohol exposure was significantly related to worse problem-solving scores, and this relationship remained after controlling for adjusted age and other substance exposure.

Conclusion: Although findings await replication with larger samples and more comprehensive measures, results suggest that unique developmental risks of prenatal opioid exposure may not persist through the first year of life. Effects of prenatal exposure to co-occurring teratogens, such as alcohol, may become apparent as children exposed to opioids develop.

Keywords: Early development; Medication-assisted treatment; Polysubstance use; Prenatal opioid exposure; Timeline follow-back interview.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

See all similar articles

References

    1. American College of Obstetrics and Gynecology (2017). Committee Opinion No. 711: Opioid use and opioid use disorder in pregnancy. Obstetrics and Gynecology, 130(2), e81–e94. 10.1097/AOG.0000000000002235 - DOI - PubMed
    1. Andersen JM, Høiseth G, & Nygaard E (2020). Prenatal exposure to methadone or buprenorphine and long-term outcomes: A meta-analysis. Early Human Development, 143, 104997. 10.1016/j.earlhumdev.2020.104997 - DOI - PubMed
    1. Azuine RE, Ji Y, Chang H-Y, Kim Y, Ji H, DiBari J, Hong X, Wang G, Singh GK, Pearson C, Zuckerman B, Surkan PJ, & Wang X (2019). Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population. JAMA Network Open, 2(6), e196405. 10.1001/jamanetworkopen.2019.6405 - DOI - PMC - PubMed
    1. Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, & Miller IW (1998). Reliability and validity of a smoking Timeline Follow-Back Interview. Psychology of Addictive Behaviors, 12(2), 101–112. 10.1037/0893-164X.12.2.101 - DOI
    1. Conradt E, Flannery T, Aschner JL, Annett RD, Croen LA, Duarte CS, Friedman AM, Guille C, Hedderson MM, Hofheimer JA, Jones MR, Ladd-Acosta C, McGrath M, Moreland A, Neiderhiser JM, Nguyen RHN, Posner J, Ross JL, Savitz DA, … Lester BM. (2019). Prenatal opioid exposure: Neurodevelopmental consequences and future research priorities. Pediatrics, 144(3), e20190128. 10.1542/peds.2019-0128 - DOI - PMC - PubMed

Publication types

Substances